CREATE Act. Licensee shall not invoke the Cooperative Research and Technology Enhancement Act of 2004, as set forth under Title 35, Section 102(c) of the United States Code (the “CREATE Act”), with respect to the Patent Rights without first obtaining the prior written consent of CSMC.
Appears in 16 contracts
Samples: Exclusive Option Agreement (Kairos Pharma, LTD.), Exclusive License Agreement (Kairos Pharma, LTD.), Exclusive Option Agreement (Kairos Pharma, LTD.)
CREATE Act. Licensee shall not invoke the Cooperative Research and Technology Enhancement Act of 2004, as set forth under Title 35, Section 102(c) of the United States Code (the “"CREATE Act”"), with respect to the Patent Rights without first obtaining the prior written consent of CSMC.
Appears in 2 contracts
Samples: Exclusive License Agreement (Innovest Global, Inc.), Exclusive License Agreement (Innovest Global, Inc.)
CREATE Act. Licensee shall not invoke the Cooperative Research and Technology Enhancement Act of 2004, as set forth under Title 35, Section 102(c) of the United States Code (the “CREATE Act”), with respect to the Patent Rights without first obtaining the prior written consent of CSMCCSMC (on behalf of Licensors).
Appears in 1 contract
